MedTrace Logo

Ultrasound Guided Femoral Nerve Block

NCT02381717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-03-03

No results posted yet for this study

Summary

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Conditions

  • Hip Fracture

Interventions

OTHER

ultra-sound guide

Patients randomized to this arm will have the femoral nerve block with the guidance of a bedside ultrasound

DRUG

bupivacaine

DRUG

morphine

Sponsors & Collaborators

Principal Investigators

  • Beatrice Hoffmann, MD PhD · Beth Israel Deaconess Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
101 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2025-05-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381717 on ClinicalTrials.gov